How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Amazon.com Inc. | €227.75 | €253.89 |
| Alphabet Inc. A | €332.30 | €336.43 |
| NVIDIA Corp. | €193.60 | €211.42 |
| Security | Price | Target price |
|---|---|---|
| Prudential Financial | €87.18 | €79.37 |
| Whirlpool Corp. | €35.38 | €80.04 |
| Southern Copper | €149.35 | €132.22 |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Cleanspark Inc. | DomRuinart | 21.73% |
| B POET Technologies Inc. | quelbe60 | 16.35% |
| B Fuelcell Energy Inc. | Traumtanz | 15.63% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S POET Technologies Inc. | Vassago1 | -31.78% |
| S Leslie S Inc. | michaelkr | -26.14% |
| S Acciona S.A. | Royal Bank of Canada | -4.85% |
Portfolios of our members
Standardsoftware
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
Rhythm Pharmaceuticals
WKN: A2H5A0 / Symbol: RYTM / Name: Rhythm Pharmaceuticals / Stock / Biotechnology & Medical Research / Small Cap /
Pros
Cons
Curis Inc.
WKN: A3ETJD / Name: Curis Inc. / Stock / ? /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Alaska Air Group Inc. | €34.02 | 9.070% |
| United Continental Holdings | €83.20 | 8.330% |
| Delta Air Lines Inc. | €63.12 | 8.060% |
| Advanced Micro Devices Inc. | €385.35 | 7.990% |
| Norwegian Cruise Line Hl. | €13.75 | 7.860% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Hasbro Inc. | €76.92 | -8.140% |
| Cabot Oil & Gas Corp | €27.72 | -8.130% |
| Analog Devices Inc. | €332.60 | -7.100% |
| CF Industries Holdings Inc. | €104.30 | -5.310% |
| SL Green Realty Corp. | ? | -5.020% |
Courses
sharewise advanced features
Also you get more information about our Pro and Cons feature, where we bring the wisdom of crowds to a new level.
For discussing with your friends and managing your investment clubs we will show you how to create your own stock debates.#
sharewise Introduction
Predictions
Top News
The Great Cloud Divide: How AI Is Reshuffling the Software Deck
Key Points
- Interested in ServiceNow, Inc.? Here are five stocks we like better.
- ServiceNow appears poised to become an indispensable AI governance backbone for the modern enterprise.
- Salesforce
Eagle Materials: A Dividend-Paying Brick & Mortar AI Play
Key Points
- Interested in Eagle Materials Inc? Here are five stocks we like better.
- Eagle Materials' diversified business is supported by infrastructure and data center demand.
- Outperformance in
Analog Devices Provides Much-Needed Pullback: How Low Can It Go?
Key Points
- Interested in Analog Devices, Inc.? Here are five stocks we like better.
- Analog Devices is well-positioned to benefit from a multi-year supercycle that could extend to a decade or
Candel Therapeutics Eyes Year-End BLA After Strong Prostate Cancer Data
Key Points
- Interested in Candel Therapeutics, Inc.? Here are five stocks we like better.
- Candel Therapeutics said it remains on track to file a BLA by year-end for aglatimagene in localized
Lowe's Companies Q1 Earnings Call Highlights
Key Points
- Interested in Lowe's Companies, Inc.? Here are five stocks we like better.
- Lowe’s posted a modest Q1 comparable sales gain of 0.6% and raised sales 10.3% year over year to $23.1
Oil & Gas Following the AI Capex Boom as Crude Hovers at $100
After more than a decade of disciplined budgeting and limited capital expenditure, oil and gas companies are opening their wallets again. The commodity supercycle of the mid-2000s left the industry
TGTX Stock Rises 29% in 3 Months: Here's What You Should Know
Shares of TG Therapeutics TGTX have risen 29% in the past three months, driven by the robust sales performance of its sole marketed drug, Briumvi (ublituximab-xiiy). The company’s top line primarily
Finanzmärkte im Wandel und wie neue digitale Dynamiken Investoren beeinflussen
News
Toll Brothers Q2 Earnings Call Highlights
Key Points
- Interested in Toll Brothers Inc.? Here are five stocks we like better.
- Toll Brothers beat second-quarter expectations with revenue of $2.5 billion, adjusted gross margin of 26.2%
Target Q1 Earnings Call Highlights
Key Points
- Interested in Target Corporation? Here are five stocks we like better.
- Target beat first-quarter expectations with net sales up 6.7% to $25.4 billion and comparable sales up 5.6%
Dorian LPG Q4 Earnings Call Highlights
Key Points
- Interested in Dorian LPG Ltd.? Here are five stocks we like better.
- Strong fourth-quarter performance: Dorian LPG said a stronger VLGC freight market helped drive Q4 results, with
Auna Q1 Earnings Call Highlights
Key Points
- Interested in Auna S.A.? Here are five stocks we like better.
- Auna posted stronger Q1 revenue and cash flow, with consolidated revenue up 10% year over year on an FX-neutral basis
Analog Devices Q2 Earnings Call Highlights
Key Points
- Interested in Analog Devices, Inc.? Here are five stocks we like better.
- Analog Devices posted record fiscal Q2 2026 results, with revenue of $3.62 billion, non-GAAP EPS of $3.09
Arhaus Stock Drops to 52-Week Low After Q1 Earnings
Key Points
- Interested in Arhaus, Inc.? Here are five stocks we like better.
- Arhaus posted record first-quarter revenue of $314 million that topped Wall Street estimates, but weakening comparable
ERNA Stock Shoots Up 140% in a Month: Here's What You Should Know
Ernexa Therapeutics’ ERNA shares rallied 140.2% in a month, primarily driven by encouraging preclinical results for its lead cell therapy candidate, ERNA-101, in ovarian cancer. The sharp stock move
Big Morning for Retail Earnings: TGT, LOW, TJX & More
Wednesday, May 20th, 2026Pre-market futures are up this morning, filling in some holes from Tuesday’s session that closed in the red. Major indexes are fighting back to all-time-high levels (on the
Pfizer Builds Oncology Growth Around Padcev and Pipeline Expansion
Pfizer PFE is one of the world’s leading oncology drugmakers, with a strong presence across breast, genitourinary, thoracic, gastrointestinal and hematologic cancers. The company has built a broad
Contest
Still running
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.








